J&J Loses Bid For New Trial In $482M Stent Patent Case
Johnson & Johnson on Tuesday suffered a blow in its battle to dodge a $482 million verdict against it for allegedly infringing a New Jersey radiologist's coronary stent patent, with a...To view the full article, register now.
Already a subscriber? Click here to view full article